CureVac
Baron Jean Stéphenne is former Chairman of GSK Biologicals and President of GSK Biologicals. He began his career with SmithKline-Rit, where he became Chairman and Chief Executive Officer. He served as the President of Union Wallonne des Entreprises (UWE) from 1997 to 2000.
Baron Jean is chairman of BESIX Group S.A./N.V. and TiGenix N.V. Additionally, he serves as chairman or director for several biotech companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
CureVac
8 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.